Long-Term Outcome After Deferral of Revascularization in Patients With Intermediate Coronary Stenosis and Gray-Zone Fractional Flow Reserve

被引:27
作者
Shiono, Yasutsugu [1 ]
Kubo, Takashi [1 ]
Tanaka, Atsushi [1 ]
Ino, Yasushi [1 ]
Yamaguchi, Tomoyuki [1 ]
Tanimoto, Takashi [1 ]
Yamano, Takashi [1 ]
Matsuo, Yoshiki [1 ]
Nishiguchi, Tsuyoshi [1 ]
Teraguchi, Ikuko [1 ]
Ota, Shingo [1 ]
Ozaki, Yuichi [1 ]
Orii, Makoto [1 ]
Shimamura, Kunihiro [1 ]
Kitabata, Hironori [1 ]
Hirata, Kumiko [1 ]
Imanishi, Toshio [1 ]
Akasaka, Takashi [1 ]
机构
[1] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan
关键词
Deferred revascularization; Fractional flow reserve; Gray zone; Intermediate coronary stenosis; FUNCTIONAL SEVERITY; ADENOSINE 5'-TRIPHOSPHATE; ARTERY-DISEASE; CATHETERIZATION; INTRACORONARY; INTERVENTION; DEFECTS; THERAPY;
D O I
10.1253/circj.CJ-14-0671
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: A strategy of deferred percutaneous coronary intervention for coronary stenosis with fractional flow reserve (FFR) 0.75-0.80, termed the gray zone, remains a matter of debate. The aim of this study was to assess the safety of deferring revascularization for patients with FFR 0.75-0.80 compared with those with FFR >0.80. Methods and Results: We assessed 3-year clinical outcome in 150 patients with angiographically intermediate stenosis who had revascularization deferred on the basis of FFR =0.75 (FFR 0.75-0.80, n=56; FFR >0.80, n=94). Target vessel failure (TVF), defined as a composite of cardiac death, target vessel-related myocardial infarction (MI), and ischemia-driven target vessel revascularization (TVR) was evaluated during follow-up. Cardiac death was observed in 1 patient with FFR 0.75-0.80. There was no target vessel-related MI in either group. The incidence of ischemiadriven TVR was higher in patients with FFR 0.75-0.80 than in those with FFR >0.80 (14% vs. 3%, P=0.020). TVF-free survival was significantly worse for the patients with FFR 0.75-0.80 than those with FFR >0.80 (hazard ratio, 5.2; 95% confidence intervals: 1.4-19.5; P=0.015). Conclusions: Patients with FFR 0.75-0.80 were at higher risk of TVF mainly due to TVR than those with FFR >0.80.
引用
收藏
页码:91 / 95
页数:5
相关论文
共 26 条
[1]   Diastolic fractional flow reserve to assess the functional severity of moderate coronary artery stenoses - Comparison with fractional flow reserve and coronary flow velocity reserve [J].
Abe, M ;
Tomiyama, H ;
Yoshida, H ;
Doba, N .
CIRCULATION, 2000, 102 (19) :2365-2370
[2]   Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis - A randomized trial [J].
Bech, GJW ;
De Bruyne, S ;
Pijls, NHJ ;
de Muinck, ED ;
Hoorntje, JC ;
Escaned, J ;
Stella, PR ;
Boersma, E ;
Bartunek, J ;
Koolen, JJ ;
Wijns, W .
CIRCULATION, 2001, 103 (24) :2928-2934
[3]   Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease [J].
Berger, A ;
Botman, KJ ;
MacCarthy, PA ;
Wijns, W ;
Bartunek, J ;
Heyndrickx, GR ;
Pijls, NHJ ;
De Bruyne, B .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :438-442
[4]   Comparison of medical treatment and coronary revascularization in patients with moderate coronary lesions and borderline fractional flow reserve measurements [J].
Courtis, Javier ;
Rodes-Cabau, Josep ;
Larose, Eric ;
Dery, Jean-Pierre ;
Nguyen, Can Manh ;
Proulx, Guy ;
Gleeton, Onil ;
Roy, Louis ;
Barbeau, Gerald ;
Noel, Bernard ;
DeLarochelliere, Robert ;
Bertrand, Olivier F. .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 71 (04) :541-548
[5]   Intracoronary and intravenous adenosine 5′-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans [J].
De Bruyne, B ;
Pijls, NHJ ;
Barbato, E ;
Bartunek, J ;
Bech, JW ;
Wijns, W ;
Heyndrickx, GR .
CIRCULATION, 2003, 107 (14) :1877-1883
[6]   Fractional flow reserve in patients with prior myocardial infarction [J].
De Bruyne, B ;
Pijls, NHJ ;
Bartunek, J ;
Kulecki, K ;
Bech, JW ;
De Winter, H ;
Van Crombrugge, P ;
Heyndrickx, GR ;
Wijns, W .
CIRCULATION, 2001, 104 (02) :157-162
[7]   Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease [J].
De Bruyne, Bernard ;
Pijls, Nico H. J. ;
Kalesan, Bindu ;
Barbato, Emanuele ;
Tonino, Pim A. L. ;
Piroth, Zsolt ;
Jagic, Nikola ;
Mobius-Winckler, Sven ;
Rioufol, Gilles ;
Witt, Nils ;
Kala, Petr ;
MacCarthy, Philip ;
Engstrom, Thomas ;
Oldroyd, Keith G. ;
Mavromatis, Kreton ;
Manoharan, Ganesh ;
Verlee, Peter ;
Frobert, Ole ;
Curzen, Nick ;
Johnson, Jane B. ;
Jueni, Peter ;
Fearon, William F. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (11) :991-1001
[8]   Effects of intravenous and intracoronary adenosine 5′-triphosphate as compared with adenosine on coronary flow and pressure dynamics [J].
Jeremias, A ;
Filardo, SD ;
Whitbourn, RJ ;
Kernoff, RS ;
Yeung, AC ;
Fitzgerald, PJ ;
Yock, PG .
CIRCULATION, 2000, 101 (03) :318-323
[9]   Physiological assessment of coronary artery disease in the cardiac catheterization laboratory - A scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology [J].
Kern, Morton J. ;
Lerman, Amir ;
Bech, Jan-Willen ;
De Bruyne, Bernard ;
Eeckhout, Eric ;
Fearon, William F. ;
Higano, Stuart T. ;
Lim, Michael J. ;
Meuwissen, Martijn ;
Piek, Jan J. ;
Pijls, Nico H. J. ;
Siebes, Maria ;
Spaan, Jos A. E. .
CIRCULATION, 2006, 114 (12) :1321-1341
[10]   Current Concepts of Integrated Coronary Physiology in the Catheterization Laboratory [J].
Kern, Morton J. ;
Samady, Habib .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (03) :173-185